Cargando…
LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway
Background and Aims: Cancer cells prefer aerobic glycolysis to maintain growth advantages, but the role of long non-coding RNAs (lncRNAs) in glycometabolism still remains unclear. Here we identified one cytoplasmic lncRNA LINC01554 as a significantly downregulated lncRNA in hepatocellular carcinoma...
Autores principales: | Zheng, Yin-Li, Li, Lei, Jia, Yong-Xun, Zhang, Bao-Zhu, Li, Jiang-Chao, Zhu, Ying-Hui, Li, Meng-Qing, He, Jiao-Zi, Zeng, Ting-Ting, Ban, Xiao-Jiao, Yuan, Yun-Fei, Li, Yan, Guan, Xin-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376468/ https://www.ncbi.nlm.nih.gov/pubmed/30809309 http://dx.doi.org/10.7150/thno.28992 |
Ejemplares similares
-
Bioinformatics analysis of LINC01554 and its co-expressed genes in hepatocellular carcinoma
por: Li, Ling, et al.
Publicado: (2020) -
Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and its Clinical Significance
por: Ding, Yuan, et al.
Publicado: (2020) -
Long Noncoding RNA LINC01554 Inhibits the Progression of NSCLC Progression by Functioning as a ceRNA for miR-1267 and Regulating ING3/Akt/mTOR Pathway
por: Wang, Zizong, et al.
Publicado: (2022) -
Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer
por: Luo, Ting, et al.
Publicado: (2021) -
LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway
por: Li, Zhihai, et al.
Publicado: (2022)